Metabolic surgery and gut hormones - A review of bariatric entero-humoral modulation

被引:77
作者
Ashrafian, Hutan [1 ,2 ]
le Roux, Carel W. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, London SW7 2AZ, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Surg Technol, London, England
关键词
Surgery; Metabolic; Bariatric; Appetite; Gut; Hormone; Obesity; GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; MORBIDLY OBESE-PATIENTS; PLASMA GHRELIN LEVELS; VERTICAL BANDED GASTROPLASTY; APOLIPOPROTEIN A-IV; INHIBITORY POLYPEPTIDE GIP; FACILITATE WEIGHT-LOSS; SMALL BOWEL BYPASS; BODY-MASS INDEX;
D O I
10.1016/j.physbeh.2009.03.012
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The global pandemic of obesity is increasing. Inappropriate food intake relative to energy expenditure results in increased adiposity. These factors are partly regulated by signals through the gut-brain and adipose-brain axes. Metabolic operations (otherwise known as Bariatric surgery) offer the most effective results for sustained metabolic improvement and weight loss. They modulate a number of gut hormones that constitute the gut-brain axis. This review summarizes the literature to-date reporting the gut hormone changes associated with these operations and their subsequent effects on appetite. Understanding the anatomical differences between each operation and how these can differentially regulate gut hormonal release can provide new treatments and targets for obesity, appetite and metabolic disorders. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:620 / 631
页数:12
相关论文
共 204 条
[1]   Blockade of the neuropeptide YY2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake [J].
Abbott, CR ;
Small, CJ ;
Kennedy, AR ;
Neary, NM ;
Sajedi, A ;
Ghatei, MA ;
Bloom, SR .
BRAIN RESEARCH, 2005, 1043 (1-2) :139-144
[2]   The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway [J].
Abbott, CR ;
Monteiro, M ;
Small, CJ ;
Sajedi, A ;
Smith, KL ;
Parkinson, JRC ;
Ghatei, MA ;
Bloom, SR .
BRAIN RESEARCH, 2005, 1044 (01) :127-131
[3]   Changes in serum ghrelin concentration following biliopancreatic diversion for obesity [J].
Adami, GF ;
Cordera, R ;
Andraghetti, G ;
Camerini, GB ;
Marinari, GM ;
Scopinaro, N .
OBESITY RESEARCH, 2004, 12 (04) :684-687
[4]   Plasma ghrelin concentratin in the short-term following biliopancreatic diversion [J].
Adami, GF ;
Cordera, R ;
Marinari, G ;
Lamerini, G ;
Andraghetti, G ;
Scopinaro, N .
OBESITY SURGERY, 2003, 13 (06) :889-892
[5]   DISTRIBUTION AND RELEASE OF HUMAN PANCREATIC POLYPEPTIDE [J].
ADRIAN, TE ;
BLOOM, SR ;
BRYANT, MG ;
POLAK, JM ;
HEITZ, P ;
BARNES, AJ .
GUT, 1976, 17 (12) :940-944
[6]   HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY [J].
ADRIAN, TE ;
FERRI, GL ;
BACARESEHAMILTON, AJ ;
FUESSL, HS ;
POLAK, JM ;
BLOOM, SR .
GASTROENTEROLOGY, 1985, 89 (05) :1070-1077
[7]  
AMLAND PF, 1984, INT J OBESITY, V8, P117
[8]  
AMLAND PF, 1984, ACTA CHIR SCAND, V150, P223
[9]   EFFECTS OF A GASTRIC PARTITIONING OPERATION FOR MORBID-OBESITY ON THE SECRETION OF GASTRIC-INHIBITORY POLYPEPTIDE AND PANCREATIC-POLYPEPTIDE [J].
AMLAND, PF ;
JORDE, R ;
KILDEBO, S ;
BURHOL, PG ;
GIERCKSKY, KE .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1984, 19 (06) :857-861
[10]   Receptor-receptor interactions as studied with microdialysis.: Focus on NTR/D2 interactions in the basal ganglia [J].
Antonelli, T. ;
Tomasini, M. C. ;
Fuxe, K. ;
Agnati, L. F. ;
Tanganelli, S. ;
Ferraro, L. .
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (01) :105-113